Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib and Taxotere in Stage D3 Prostate Cancer
NCT00215345Phase 2Unknown
- Sponsor
- United States Department of Veterans Affairs
- Start
- Aug 2002
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib in prostate cancer (PCa), sponsored by United States Department of Veterans Affairs. Status: unknown.
02
Drugs
celecoxib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00215345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00215345.